アプタマー アフェレシス 核酸医薬の開発|タグシクス・バイオ株式会社

Vision / Misson

Our Mission

Producing better and safer medicines through artificial oligonucleotide DNA aptamer technology

TAGCyx Bio can create DNA aptamers through drug discovery platform technology “Xenoligo®” based on innovative artificial base pairing technology. Aptamers are the next generation drug modality consisting of single-stranded oligonucleotide molecules. We will produce more effective and safer medicines and medical devices and contribute to society by delivering therapies to as many people as possible at low cost.

Our Features

  • We can create superior oligonucleotide aptamers, Xenoligo®, using our world-leading proprietary artificial base pairing technology.
  • By creating oligonucleotide aptamers, which are chemical antibodies that can replace antibody drugs, we can reduce side effects, diversify administration routes, and contribute to the improvement of healthcare economics.
  • oligonucleotide aptamers can be applied to medical devices such as apheresis and diagnostic reagents to create products that outperform existing technologies.